monoclonal antibodies
AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials
October 4, 2026Asthma & COPD, COPD, asthma, clinical trials, monoclonal antibodies
AstraZeneca’s tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) in two phase 3 trials, cutting exacerbation …
Gilead inks deal with Canadian antibody discovery firm AbCellera
June 14, 2019Medical Communications AbCellera, Gilead, monoclonal antibodies, pharma
Gilead has entered into an agreement with Canadian monoclonal antibody discovery firm AbCellera. The two firms will take part in …
Edinburgh researchers genetically modify chickens to produce medicine filled eggs
January 29, 2019Manufacturing and Production Edinburgh, cancer drugs, medicines, monoclonal antibodies, proteins
Researchers at the University of Edinburgh have genetically modified chickens, meaning that they lay eggs containing human proteins which can …
Shire signs antibody research deal with arGEN-X
February 29, 2012Research and Development Shire, arGEN-X, monoclonal antibodies
Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
October 6, 2026
Brenntag and dsm-firmenich expand biopharma vitamin partnership
October 4, 2026
